Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kenju Fujita"'
Autor:
Barry L. Dowell, Toru Yoshimura, Sabrina S. Chan, Gangamani S. Beligere, Katsumichi Takeda, Kenju Fujita, Satoshi Kawakami
Publikováno v:
Tumor Biology. 29:224-230
Although serum assays for pro-gastrin-releasing peptide (ProGRP) assays have been commercially available in Japan for several years, the stability of ProGRP in serum and plasma has not been well documented. We investigated the stability of ProGRP in
Publikováno v:
Clinical biochemistry. 48(18)
Objectives Protein induced by vitamin K absence or antagonist II (PIVKA-II), an abnormal form of prothrombin, has been used as an aid in the diagnosis of hepatocellular cancer (HCC) as a tumor marker. We developed a fully automated quantitative immun
Autor:
Gangamani S. Beligere, Petra Stieber, Yoshiharu Matsuoka, Cornelia Scheuer, Sabrina S. Chan, Rahul D. Patil, Karin Hofmann, Yousuke Sakurai, Debra J. Elliott, Barry L. Dowell, Haruhisa Saegusa, Hideki Kinukawa, Kenju Fujita, Ken Yamaguchi, Masayuki Iizuka, Toru Yoshimura, Daniel W. Chan, Lori J. Sokoll
Publikováno v:
Clinical chemistry and laboratory medicine. 47(12)
Background: Pro-gastrin releasing peptide (ProGRP) concentrations in blood play an important role in the diagnosis and treatment of patients with small cell lung cancer (SCLC). The automated quantitative ARCHITECT® ProGRP assay was developed to aid